EGFR and lung adenocarcinoma: The purpose of this study was to identify the prognostic value of a combined assessment of serum markers in patients with lung adenocarcinoma and bone metastases undergoing EGFR-TKI treatment and to provide more accurate personalized treatment planning for clinical practices.